Skip to main content
TipRanks
Go Ultimate75% OFF

Everest Medicines Ltd. (1952) Income Statement

5 Followers

Everest Medicines Ltd. Income Statement

Last quarter (Q2 2026), Everest Medicines Ltd.'s total revenue was ¥573.92M, an increase of 157.29% from the same quarter last year. In Q2, Everest Medicines Ltd.'s net income was ¥-2.97M. See Everest Medicines Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 1.71B¥ 706.68M¥ 125.93M¥ 12.79M¥ 54.00K
¥ 1.18B¥ 528.89M¥ 91.52M¥ 8.15M¥ 31.00K
¥ 1.57B¥ 1.65B¥ 1.02B¥ 264.95M¥ 1.03B
Depreciation and Amortization¥ 156.52M¥ 133.62M¥ 76.78M¥ 42.77M¥ 31.12M
¥ -187.37M¥ -646.59M¥ -744.63M¥ -198.91M¥ -972.78M
¥ -386.24M¥ -1.12B¥ -932.74M¥ -256.80M¥ -1.03B
¥ -212.12M¥ 75.67M¥ 88.28M¥ 9.53M¥ 17.61M
¥ -598.36M¥ -1.04B¥ -844.46M¥ -247.28M¥ -1.01B
¥ -297.77M¥ -1.04B¥ -844.46M¥ -247.28M¥ -1.01B
Per Share Metrics
Basic EPS¥ -0.89¥ -3.24¥ -2.70¥ -0.83¥ -3.44
Diluted EPS¥ -0.89¥ -3.24¥ -2.70¥ -0.83¥ -3.44
Weighted Average Shares Outstanding334.57M320.92M313.06M297.63M293.23M
Weighted Average Shares Outstanding (Diluted)336.46M320.92M313.06M297.63M293.27M

Currency in CNY

Everest Medicines Ltd. Earnings and Revenue History

-8B-4B04B-2400000 %-1600000 %-800000 %0 %EarningsProfit Margin20182019202020212022202320242025RevenueEarningsProfit Margin